CABALA | Key publications

CABALA publications

• Conference Proceedings of the 4^th Microbiome R&D and Business Collaboration Forum, and Probiotics Congress, April 3–4, 2017, Amsterdam, The Netherlands - Le DH. EBioMedicine. 2017 May;19:2-3. doi: 10.1016/j.ebiom.2017.04.019. Epub 2017 Apr 13.

STATE of ART bibliography

• Interactions between gut bacteria and bile in health and disease. Long SL, Gahan CGM, Joyce SA. Mol Aspects Med. 2017 Jun 9. pii: S0098-2997(16)30120-0. doi: 10.1016/j.mam.2017.06.002. [Epub ahead of print] Review.
• Crosstalk between Bile Acids and Gut Microbiota and Its Impact on Farnesoid X Receptor Signalling. Wahlström A, Kovatcheva-Datchary P, Ståhlman M, Bäckhed F, Marschall HU. Dig Dis. 2017;35(3):246-250. doi: 10.1159/000450982. Epub 2017 Mar 1. Review.
• The role of neuromedin U in adiposity regulation. Haplotype analysis in European children from the IDEFICS Cohort. Gianfagna F, Grippi C, Ahrens W, Bailey ME, Börnhorst C, De Henauw S, Foraita R, Koni AC, Krogh V, Mårild S, Molnár D, Moreno L, Pitsiladis Y, Russo P, Siani A, Tornaritis M, Veidebaum T, Iacoviello L. PLoS One. 2017 Feb 24;12(2):e0172698. doi: 10.1371/journal.pone.0172698. eCollection 2017.
• Disease-Associated Changes in Bile Acid Profiles and Links to Altered Gut Microbiota. Joyce SA, Gahan CG. Dig Dis. 2017;35(3):169-177. doi: 10.1159/000450907. Epub 2017 Mar 1. Review.
• Prevalence of abdominal aortic aneurysms and its relation with cardiovascular risk stratification: protocol of the Risk of Cardiovascular diseases and abdominal aortic Aneurysm in Varese (RoCAV) population based study. Gianfagna F, Veronesi G, Bertù L, Tozzi M, Tarallo A, Ferrario MM, Castelli P; RoCAV Project Investigators. BMC Cardiovasc Disord. 2016 Nov 29;16(1):243.
• Dietary fat and gut microbiota interactions determine diet-induced obesity in mice. Kübeck R, Bonet-Ripoll C, Hoffmann C, Walker A, Müller VM, Schüppel VL, Lagkouvardos I, Scholz B, Engel KH, Daniel H, Schmitt-Kopplin P, Haller D, Clavel T, Klingenspor M. Mol Metab. 2016 Oct 13;5(12):1162-1174. eCollection 2016 Dec.
• Unconjugated Bile Acids Influence Expression of Circadian Genes: A Potential Mechanism for Microbe-Host Crosstalk. Govindarajan K, MacSharry J, Casey PG, Shanahan F, Joyce SA, Gahan CG. PLoS One. 2016 Dec 1;11(12):e0167319. doi: 10.1371/journal.pone.0167319. eCollection 2016.
• Bile Acid Modifications at the Microbe-Host Interface: Potential for Nutraceutical and Pharmaceutical Interventions in Host Health. Joyce SA, Gahan CG. Annu Rev Food Sci Technol. 2016;7:313-33. doi: 10.1146/annurev-food-041715-033159. Epub 2016 Jan 11. Review. 
• Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism. Zhang L, Xie C, Nichols RG, Chan SH, Jiang C, Hao R, Smith PB, Cai J, Simons MN, Hatzakis E, Maranas CD, Gonzalez FJ, Patterson AD. mSystems. 2016 Oct 11;1(5). pii: e00070-16. eCollection 2016 Sep-Oct. 
• Influence of sleep disturbances on age at onset and long-term incidence of major cardiovascular events: the MONICA-Brianza and PAMELA cohort studies. Gianfagna F, Veronesi G, Bertù L, Cesana G, Grassi G, Stranges S, Callegari C, Ferrario MM. Sleep Med. 2016 May;21:126-32. doi: 10.1016/j.sleep.2016.01.007. Epub 2016 Feb 12.
• The gut microbiota and host health: a new clinical frontier. Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, Quraishi MN, Kinross J, Smidt H, Tuohy KM, Thomas LV, Zoetendal EG, Hart A. Gut. 2016 Feb;65(2):330-9. doi: 10.1136/gutjnl-2015-309990. Epub 2015 Sep 2. Review.  
• Insulin Resistance, Microbiota, and Fat Distribution Changes by a New Model of Vertical Sleeve Gastrectomy in Obese Rats. Basso N, Soricelli E, Castagneto-Gissey L, Casella G, Albanese D, Fava F, Donati C, Tuohy K, Angelini G, La Neve F, Severino A, Kamvissi-Lorenz V, Birkenfeld AL, Bornstein S, Manco M, Mingrone G. Diabetes. 2016 Oct;65(10):2990-3001. doi: 10.2337/db16-0039. Epub 2016 Jul 18. 
• Hypocholesterolemic and Prebiotic Effects of a Whole-Grain Oat-Based Granola Breakfast Cereal in a Cardio-Metabolic "At Risk" Population. Connolly ML, Tzounis X, Tuohy KM, Lovegrove JA. Front Microbiol. 2016 Nov 7;7:1675. eCollection 2016. 
• Apples and cardiovascular health--is the gut microbiota a core consideration? Koutsos A, Tuohy KM, Lovegrove JA. Nutrients. 2015 May 26;7(6):3959-98. doi: 10.3390/nu7063959. Review.  
• Changes in bile acids, FGF-19 and sterol absorption in response to bile salt hydrolase active L. reuteri NCIMB 30242. Martoni CJ, Labbé A, Ganopolsky JG, Prakash S, Jones ML. Gut Microbes. 2015;6(1):57-65. doi: 10.1080/19490976.2015.1005474. 
• Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Joyce SA, MacSharry J, Casey PG, Kinsella M, Murphy EF, Shanahan F, Hill C, Gahan CG. Proc Natl Acad Sci U S A. 2014 May 20;111(20):7421-6. doi: 10.1073/pnas.1323599111. Epub 2014 May 5. 
• The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome 'at-risk' population. Fava F, Gitau R, Griffin BA, Gibson GR, Tuohy KM, Lovegrove JA. Int J Obes (Lond). 2013 Feb;37(2):216-23. doi: 10.1038/ijo.2012.33. Epub 2012 Mar 13. 
• Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial. Jones ML, Martoni CJ, Prakash S. Eur J Clin Nutr. 2012 Nov;66(11):1234-41. doi: 10.1038/ejcn.2012.126. Epub 2012 Sep 19.  
• Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillusreuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. Jones ML, Martoni CJ, Parent M, Prakash S. Br J Nutr. 2012 May;107(10):1505-13. doi: 10.1017/S0007114511004703. Epub 2011 Nov 9.